Felita’s Love is a non-profit organization founded in memory of Felita Rollins who succumbed to colon cancer in 2005, Kentisha Mazeke mother was only 45 years old at the time of her death.To honor her life, Mazeke created the foundation to provide community outreach, and awareness on colon cancer – the second leading cause of cancer death among men and women combined in the United States.
“We focus on promoting positive mental health by providing emotional support to women who feel stuck in the perils of life and are dealing with grief and loss,” said Mazeke. She continued, “With support, love empowers, equips, and inspires women to overcome adversity and turn their pain into purpose.”
One of its major events, held during march Which is Colon Cancer Awareness Month, Felita’s Love held the inaugural Hearts for Blue Colon Cancer Awareness Brunch to celebrate love, life and hope. Keynote Speaker was Grace De La Rosa, a Stage III Colon Cancer Survivor and advocate. Ambassadors, Ronnie and Sherri Ard with Fight Colorectal Cancer (Fight CRC) also traveled from Pensacola, Florida to educate attendees on colon cancer and provided information and resources to attendees. Honored for her advocacy was Mrs. Tiffany Ortiz, a 34 year old, wife, mother of three and former Registered Nurse and Stage IV Colon Cancer fighter.
Mrs. Ortiz was diagnosed with colon cancer at 32 years old shortly after the birth of her daughter. Due to her declining health, Tiffany had to quit her job of eight years. During the event a silent auction was held to raise money for Tiffany’s increased medical expenses and treatments. Despite her diagnosis, Tiffany remains hopeful as she continues to inspire others because of the courage and strength she exudes. Family and friends traveled near and far to support and celebrate their warrior who they affectionately refer to as #TiffanyStrong and she is indeed a strong warrior.To learn more about Tiffany’s story and to donate, please visit her GoFundMe at https://www.gofundme.com/f/mndrdm-help-tiffany-fight-cancer
Be the first to comment